Screening for Familial Hypercholesterolemia in Children and its Cost-Effectiveness.
作者信息
Nagahara Keiko
机构信息
Department of Pediatrics, Showa Medical University School of Medicine.
出版信息
J Atheroscler Thromb. 2025 Aug 1;32(8):926-928. doi: 10.5551/jat.ED285. Epub 2025 Jun 5.
Abstract
摘要
相似文献
1
Screening for Familial Hypercholesterolemia in Children and its Cost-Effectiveness.儿童家族性高胆固醇血症的筛查及其成本效益
J Atheroscler Thromb. 2025 Aug 1;32(8):926-928. doi: 10.5551/jat.ED285. Epub 2025 Jun 5.
2
A Cost-Effectiveness Analysis for the Combination of Universal Screening at 9-10 Years Old and Reverse Cascade Screening of Relatives for Familial Hypercholesterolemia in Japan.日本9至10岁普遍筛查与家族性高胆固醇血症亲属反向级联筛查相结合的成本效益分析。
J Atheroscler Thromb. 2025 Aug 1;32(8):962-981. doi: 10.5551/jat.65181. Epub 2025 Feb 14.
3
Statins for children with familial hypercholesterolemia.用于家族性高胆固醇血症儿童的他汀类药物。
Cochrane Database Syst Rev. 2010 Jul 7(7):CD006401. doi: 10.1002/14651858.CD006401.pub2.
4
The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.家族性高胆固醇血症基因筛查的成本效益：一项系统评价
Ann Ig. 2017 Sep-Oct;29(5):464-480. doi: 10.7416/ai.2017.2178.
5
Statins for children with familial hypercholesterolemia.用于患有家族性高胆固醇血症儿童的他汀类药物。
Cochrane Database Syst Rev. 2017 Jul 7;7(7):CD006401. doi: 10.1002/14651858.CD006401.pub4.
6
Statins for children with familial hypercholesterolemia.用于家族性高胆固醇血症儿童的他汀类药物。
Cochrane Database Syst Rev. 2014 Jul 23(7):CD006401. doi: 10.1002/14651858.CD006401.pub3.
7
A systematic review of cost-effectiveness analysis of different screening strategies for familial hypercholesterolemia.家族性高胆固醇血症不同筛查策略的成本效益分析的系统评价。
J Clin Lipidol. 2024 Jan-Feb;18(1):e21-e32. doi: 10.1016/j.jacl.2023.11.001. Epub 2023 Nov 7.
8
Familial hypercholesterolemia: A systematic review of modeling studies on screening interventions.家族性高胆固醇血症：筛查干预建模研究的系统评价
Atherosclerosis. 2022 Aug;355:15-29. doi: 10.1016/j.atherosclerosis.2022.06.1011. Epub 2022 Jun 21.
9
10
Evinacumab-dgnb (Evkeeza-REGN1500), A Novel Lipid-Lowering Therapy for Homozygous Familial Hypercholesterolemia.依洛尤单抗（瑞百安），一种用于治疗纯合子家族性高胆固醇血症的新型降脂疗法。
Cardiol Rev. 2024;32(2):180-185. doi: 10.1097/CRD.0000000000000522. Epub 2023 Apr 18.
本文引用的文献
1
A Cost-Effectiveness Analysis for the Combination of Universal Screening at 9-10 Years Old and Reverse Cascade Screening of Relatives for Familial Hypercholesterolemia in Japan.日本9至10岁普遍筛查与家族性高胆固醇血症亲属反向级联筛查相结合的成本效益分析。
J Atheroscler Thromb. 2025 Aug 1;32(8):962-981. doi: 10.5551/jat.65181. Epub 2025 Feb 14.
2
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review.家族性高胆固醇血症筛查策略的成本效益：一项更新的系统评价。
Pharmacoeconomics. 2024 Apr;42(4):373-392. doi: 10.1007/s40273-023-01347-7. Epub 2024 Jan 24.
3
Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands.荷兰全国范围内儿童家族性高胆固醇血症病例发现计划的成本效益和投资回报。
JAMA Pediatr. 2023 Jun 1;177(6):625-632. doi: 10.1001/jamapediatrics.2023.0763.
4
Direct LDL-C estimation in preschoolers: Practicable first step for FH screening.学龄前儿童直接低密度脂蛋白胆固醇（LDL-C）测定：家族性高胆固醇血症（FH）筛查的可行第一步。
J Clin Lipidol. 2023 Mar-Apr;17(2):255-260. doi: 10.1016/j.jacl.2023.02.004. Epub 2023 Feb 22.
5
Cost-Effectiveness of Pediatric Universal Screening for Familial Hypercholesterolemia in Argentina.阿根廷儿童家族性高胆固醇血症普遍筛查的成本效益
Value Health Reg Issues. 2023 Jan;33:33-41. doi: 10.1016/j.vhri.2022.08.009. Epub 2022 Oct 6.
6
Screening in children for familial hypercholesterolaemia: start now.对儿童进行家族性高胆固醇血症筛查：现在就开始。
Eur Heart J. 2022 Sep 7;43(34):3209-3212. doi: 10.1093/eurheartj/ehac224.
7
Pilot study of universal screening of children and child-parent cascade testing for familial hypercholesterolaemia in Australia.澳大利亚儿童和儿童-父母级联检测家族性高胆固醇血症的普筛初步研究。
J Paediatr Child Health. 2022 Feb;58(2):281-287. doi: 10.1111/jpc.15700. Epub 2021 Aug 13.
8
Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?儿童家族性高胆固醇血症早期筛查和治疗的健康经济评价：投资回报多多？
Atherosclerosis. 2020 Jul;304:1-8. doi: 10.1016/j.atherosclerosis.2020.05.007. Epub 2020 May 20.
9
Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.1-2 岁时进行普遍筛查以作为英国家族性高胆固醇血症级联检测的辅助手段：成本效用分析。
Atherosclerosis. 2018 Aug;275:434-443. doi: 10.1016/j.atherosclerosis.2018.05.047. Epub 2018 Jun 4.
10
The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.波兰家族性高胆固醇血症筛查策略的成本效益分析。
Atherosclerosis. 2018 Mar;270:132-138. doi: 10.1016/j.atherosclerosis.2018.01.036. Epub 2018 Jan 31.
Zotero 插件